13.4 Cardiac patches and myocardial regeneration

Cardiac patches are engineered tissues designed to repair damaged hearts. They combine biomaterials, cells, and bioactive molecules to mimic heart muscle and promote healing. These patches aim to provide mechanical support and stimulate tissue regeneration in injured areas of the heart.

Creating effective cardiac patches involves careful material selection and advanced fabrication techniques. Ideal patches should be biocompatible, biodegradable, and match the heart's mechanical properties. Researchers are exploring various biomaterials and methods to optimize patch design and improve their integration with existing heart tissue.

Cardiac Patch Design

Key Components and Functions

Top images from around the web for Key Components and Functions

• 

  Frontiers | Recent Development in Therapeutic Cardiac Patches View original

  Is this image relevant?

• 

  Frontiers | Cells, Materials, and Fabrication Processes for Cardiac Tissue Engineering View original

  Is this image relevant?

• 

  Frontiers | Bioengineering Technologies for Cardiac Regenerative Medicine View original

  Is this image relevant?

• 

  Frontiers | Recent Development in Therapeutic Cardiac Patches View original

  Is this image relevant?

• 

  Frontiers | Cells, Materials, and Fabrication Processes for Cardiac Tissue Engineering View original

  Is this image relevant?

1 of 3

Top images from around the web for Key Components and Functions

• 

  Frontiers | Recent Development in Therapeutic Cardiac Patches View original

  Is this image relevant?

• 

  Frontiers | Cells, Materials, and Fabrication Processes for Cardiac Tissue Engineering View original

  Is this image relevant?

• 

  Frontiers | Bioengineering Technologies for Cardiac Regenerative Medicine View original

  Is this image relevant?

• 

  Frontiers | Recent Development in Therapeutic Cardiac Patches View original

  Is this image relevant?

• 

  Frontiers | Cells, Materials, and Fabrication Processes for Cardiac Tissue Engineering View original

  Is this image relevant?

1 of 3

• Cardiac patches are engineered tissue constructs designed to mimic the structure and function of native myocardial tissue for the purpose of regenerating damaged heart muscle
• The main components of cardiac patches include biomaterials, cells, and bioactive molecules that work together to promote tissue regeneration and improve cardiac function
  • Biomaterials provide structural support and a suitable environment for cell growth and differentiation (collagen, fibrin, or synthetic polymers)
  • Cells, such as stem cells or mature cardiac cells, are incorporated to replace lost tissue and promote regeneration (cardiomyocytes, endothelial cells, or mesenchymal stem cells)
  • Bioactive molecules, such as growth factors or cytokines, are included to stimulate cell survival, differentiation, and angiogenesis (vascular endothelial growth factor or insulin-like growth factor-1)
• Cardiac patches are designed to provide mechanical support to the damaged myocardium, while also delivering cells and growth factors to stimulate tissue regeneration and angiogenesis

Ideal Properties and Fabrication Techniques

• The ideal cardiac patch should be biocompatible, biodegradable, and possess mechanical properties similar to native myocardial tissue to ensure proper integration and function
  • Biocompatibility ensures that the patch does not elicit an adverse immune response or cause inflammation
  • Biodegradability allows the patch to be gradually replaced by newly formed tissue over time
  • Matching the mechanical properties of the myocardium, such as stiffness and elasticity, promotes seamless integration and synchronous contraction
• The patch design should allow for adequate nutrient and oxygen diffusion to support cell survival and function, as well as electrical conductivity to facilitate synchronous contraction with the host myocardium
  • Porous structures or incorporated vascular networks can enhance nutrient and oxygen transport throughout the patch
  • Electrically conductive materials, such as gold nanoparticles or carbon nanotubes, can be incorporated to improve electrical signal propagation
• The fabrication of cardiac patches often involves advanced tissue engineering techniques, such as 3D bioprinting, electrospinning, or decellularization of native tissues to create a suitable scaffold for cell seeding and growth
  • 3D bioprinting allows for precise control over the spatial distribution of cells and biomaterials to create complex, tissue-like structures
  • Electrospinning produces nanofibrous scaffolds with high surface area-to-volume ratios, promoting cell attachment and growth
  • Decellularization of native tissues, such as pericardium or myocardium, provides a natural scaffold with preserved extracellular matrix composition and structure

Biomaterials for Cardiac Patches

Types of Biomaterials

• Biomaterials used in cardiac patches can be natural, synthetic, or a combination of both, and should be biocompatible, biodegradable, and possess suitable mechanical properties for myocardial tissue engineering
• Natural biomaterials include:
  • Collagen: the main structural protein in the extracellular matrix, providing a natural substrate for cell attachment and growth
  • Fibrin: a fibrous protein involved in blood clotting, can be used to create injectable or moldable scaffolds
  • Alginate: a polysaccharide derived from brown algae, forms hydrogels with tunable mechanical properties
  • Decellularized extracellular matrix (ECM) derived from various tissue sources, such as pericardium or small intestinal submucosa, provides a natural scaffold with preserved biochemical and structural cues
• Synthetic biomaterials include polymers like:
  • Polyglycolic acid (PGA): a biodegradable polyester with high mechanical strength, commonly used in tissue engineering
  • Polylactic acid (PLA): a biodegradable polyester with slower degradation rates compared to PGA
  • Poly(lactic-co-glycolic acid) (PLGA): a copolymer of PLA and PGA, offering tunable degradation rates and mechanical properties
  • Polyurethanes: a class of polymers with excellent elasticity and biocompatibility, suitable for soft tissue engineering

Selection Criteria and Considerations

• The choice of biomaterial depends on factors such as biocompatibility, degradation rate, mechanical strength, and the ability to support cell attachment, growth, and differentiation
  • Biocompatibility is crucial to avoid adverse immune reactions and ensure long-term success of the cardiac patch
  • Degradation rate should match the rate of new tissue formation to maintain structural integrity and prevent mechanical failure
  • Mechanical strength should be sufficient to withstand the dynamic forces in the heart while not impeding contraction and relaxation
  • The biomaterial should provide a suitable environment for cell adhesion, proliferation, and differentiation into mature cardiac tissue
• Combining different biomaterials, such as natural and synthetic polymers, can leverage the advantages of each material and create composite scaffolds with improved properties
  • For example, combining collagen with PLA can enhance the mechanical strength and degradation stability of the scaffold while maintaining the biological benefits of collagen
• Surface modifications, such as incorporating adhesion molecules or growth factors, can further improve cell-material interactions and promote tissue regeneration
  • Coating the biomaterial surface with cell adhesion molecules, such as RGD peptides or laminin, can enhance cell attachment and spreading
  • Incorporating growth factors, such as vascular endothelial growth factor (VEGF) or fibroblast growth factor (FGF), can stimulate angiogenesis and tissue regeneration

Cardiac Patch Delivery and Integration

Surgical and Minimally Invasive Techniques

• Cardiac patches can be delivered to the damaged myocardium through various surgical and minimally invasive techniques to ensure proper integration and functionality
• Open-chest surgery, such as sternotomy or thoracotomy, allows for direct visualization and placement of the cardiac patch onto the epicardial surface of the heart
  • The patch can be sutured or glued to the myocardium to ensure stable attachment and prevent dislodgement
  • This approach is more invasive but allows for precise positioning of larger patches
  • Sternotomy involves cutting through the sternum to access the heart, while thoracotomy involves making an incision between the ribs
• Minimally invasive techniques, such as endoscopic or catheter-based delivery, can be used to deliver smaller cardiac patches to the damaged myocardium
  • These techniques involve accessing the heart through small incisions or blood vessels, reducing surgical trauma and recovery time
  • Endoscopic delivery uses small, flexible instruments and cameras inserted through keyhole incisions to visualize and manipulate the patch
  • Catheter-based delivery involves guiding a small, flexible tube (catheter) through blood vessels to reach the heart and deploy the patch
  • Specialized devices, such as injectable hydrogels or self-expanding scaffolds, can be used to facilitate patch deployment and attachment to the myocardium

Promoting Integration and Vascularization

• The timing of cardiac patch delivery is important, as early intervention after myocardial infarction can limit the extent of scar formation and improve the chances of successful tissue regeneration
  • Delivering the patch within the first few days to weeks after infarction can take advantage of the acute inflammatory response and enhanced cellular recruitment
  • Delayed delivery may be necessary in some cases to allow for stabilization of the infarct area and patient condition
• To promote integration with the host myocardium, the cardiac patch should be designed to allow for adequate vascularization and electrical coupling with the surrounding tissue
• Incorporating angiogenic factors or pre-vascularizing the patch can enhance blood vessel formation and improve nutrient and oxygen supply to the cells within the patch
  • Angiogenic factors, such as VEGF or FGF, can be incorporated into the patch to stimulate blood vessel growth from the host tissue
  • Pre-vascularization involves culturing the patch with endothelial cells or creating microchannels to form a rudimentary vascular network before implantation
• Using electrically conductive biomaterials or aligning the cells within the patch can facilitate synchronous contraction and electrical integration with the host myocardium
  • Incorporating conductive materials, such as gold nanoparticles or carbon nanotubes, can improve electrical signal propagation throughout the patch
  • Aligning the cells, particularly cardiomyocytes, along the direction of the myocardial fibers can promote coordinated contraction and reduce arrhythmia risk

Cardiac Patch Efficacy in Heart Repair

Preclinical Studies in Animal Models

• Preclinical studies using animal models of myocardial infarction have demonstrated the potential of cardiac patches to improve heart function and promote tissue regeneration
• Studies in small animal models, such as mice and rats, have shown that cardiac patches can:
  • Reduce scar size: the patch can limit the extent of fibrosis and replace the scar tissue with regenerated myocardium
  • Increase vascularization: the patch can stimulate blood vessel growth, improving blood supply to the infarcted area
  • Improve left ventricular function: the patch can enhance the pumping ability of the heart, as measured by parameters such as ejection fraction or fractional shortening
• Large animal models, such as pigs and sheep, have been used to assess the scalability and translational potential of cardiac patches, with promising results in terms of:
  • Patch integration: the patch can successfully engraft onto the myocardium and become vascularized and innervated
  • Functional improvement: the patch can improve cardiac function and prevent or reverse the progression of heart failure
• The efficacy of cardiac patches in preclinical studies depends on factors such as the patch composition, cell type, delivery method, and timing of intervention
  • Patches incorporating stem cells or multiple cell types have shown enhanced regenerative potential compared to acellular patches or single cell type patches
  • Delivering patches early after myocardial infarction has demonstrated better outcomes in terms of limiting scar formation and improving cardiac function

Clinical Trials and Translational Challenges

• Clinical studies on cardiac patches are limited but have shown some promising results in patients with ischemic heart disease
• Small-scale clinical trials have demonstrated the safety and feasibility of delivering cardiac patches to the damaged myocardium in humans
  • These studies have shown that cardiac patches can be successfully implanted without causing major adverse events or immune reactions
  • Some studies have reported improvements in cardiac function, such as increased left ventricular ejection fraction and reduced scar size, in patients treated with cardiac patches compared to standard medical therapy
• However, the long-term efficacy and safety of cardiac patches in humans remain to be fully established, and larger, randomized controlled trials are needed to validate their clinical potential
• Challenges in clinical translation include:
  • Optimizing patch design and delivery methods for human use, considering factors such as patch size, thickness, and mechanical properties
  • Ensuring consistent product quality and safety, including rigorous testing for sterility, potency, and stability
  • Selecting appropriate patient populations for treatment, based on factors such as infarct size, location, and time since injury
  • Addressing regulatory and ethical considerations, such as obtaining approval for clinical trials and ensuring informed consent
• Future studies should also focus on understanding the mechanisms underlying the regenerative effects of cardiac patches and identifying biomarkers to predict patient response to treatment
  • Investigating the cellular and molecular pathways involved in patch-mediated tissue regeneration can guide the development of more effective patch designs
  • Identifying biomarkers, such as circulating factors or imaging parameters, can help stratify patients and monitor treatment outcomes